The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration
Open accessAbstract
BACKGROUND: Nephropathy induced by exposure to radiocontrast agents, a possible complication of percutaneous coronary interventions, is associated with significant in-hospital and long-term morbidity and mortality. Patients with preexisting renal failure are at particularly high risk. We investigated the role of hemofiltration, as compared with isotonic-saline hydration, in preventing contrast-agent-induced nephropathy in patients with renal failure. METHODS: We studied 114 consecutive patients with chronic renal failure (serum creatinine concentration, >2 mg per deciliter [176.8 micromol per liter]) who were undergoing coronary interventions. We randomly assigned them to either hemofiltration in an intensive care unit (ICU) (58 patients, with a mean [+/-SD] serum creatinine concentration of 3.0+/-1.0 mg per deciliter [265.2+/-88.4 micromol per liter]) or isotonic-saline hydration at a rate of 1 ml per kilogram of body weight per hour given in a step-down unit (56 patients, with a mean serum creatinine concentration of 3.1+/-1.0 mg per deciliter [274.0+/-88.4 micromol per liter]). Hemofiltration (fluid replacement rate, 1000 ml per hour without weight loss) and saline hydration were initiated 4 to 8 hours before the coronary intervention and were continued for 18 to 24 hours after the procedure was completed. RESULTS: An increase in the serum creatinine concentration of more than 25 percent from the base-line value after the coronary intervention occurred less frequently among the patients in the hemofiltration group than among the control patients (5 percent vs. 50 percent, P<0.001). Temporary renal-replacement therapy (hemodialysis or hemofiltration) was required in 25 percent of the control patients and in 3 percent of the patients in the hemofiltration group. The rate of in-hospital events was 9 percent in the hemofiltration group and 52 percent in the control group (P<0.001). In-hospital mortality was 2 percent in the hemofiltration group and 14 percent in the control group (P=0.02), and the cumulative one-year mortality was 10 percent and 30 percent, respectively (P=0.01). CONCLUSIONS: In patients with chronic renal failure who are undergoing percutaneous coronary interventions, periprocedural hemofiltration given in an ICU setting appears to be effective in preventing the deterioration of renal function due to contrast-agent-induced nephropathy and is associated with improved in-hospital and long-term outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
The effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Solomon, R., Werner, C., Mann, D., D'Elia, J., & Silva, P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312104 · Cited by 1,254
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., Murphy, M. J., Halpern, E. F., Hill, J. A., Winniford, M., Cohen, M. B., VanFossen, D. B., et al. (1995) · Kidney International · doi:10.1038/ki.1995.32 · Cited by 923
Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., Perruchoud, A. P., Eriksson, U., Marsch, S., & Roskamm, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.329 · Cited by 806
Gruberg, L., Mintz, G. S., Mehran, R., Dangas, G., Lansky, A. J., Kent, K. M., Pichard, A. D., Satler, L. F., & Leon, M. B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00917-7 · Cited by 749
Best, P. J. M., Lennon, R., Ting, H. H., Bell, M. R., Rihal, C. S., Holmes, D. R., & Berger, P. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01745-x · Cited by 731
Acetylcysteine and contrast agent-associated nephrotoxicity
Briguori, C., Manganelli, F., Scarpato, P., Elia, P. P., Golia, B., Riviezzo, G., Lepore, S., Librera, M., Villari, B., Colombo, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01958-7 · Cited by 360
Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)
Diaz-Sandoval, L. J., Kosowsky, B. D., & Losordo, D. W. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02243-3 · Cited by 350
MURPHY, S. W., BARRETT, B. J., & PARFREY, P. S. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111177 · Cited by 330
Jungers, P., Massy, Z., Khoa, T., Fumeron, C., Labrunie, M., Lacour, B., Descamps-Latscha, B., & Man, N. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2597 · Cited by 321
Vogt, B., Ferrari, P., Schönholzer, C., Marti, H.-P., Mohaupt, M., Wiederkehr, M., Cereghetti, C., Serra, A., Huynh-Do, U., Uehlinger, D., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00983-4 · Cited by 290
Rich, M. W. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390180067011 · Cited by 257
Marenzi, G., Lauri, G., Grazi, M., Assanelli, E., Campodonico, J., & Agostoni, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01479-6 · Cited by 255
Self-citationAcute renal failure requiring dialysis after percutaneous coronary interventions
Gruberg, L., Mehran, R., Dangas, G., Mintz, G. S., Waksman, R., Kent, K. M., Pichard, A. D., Satler, L. F., Wu, H., & Leon, M. B. (2001) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.1093 · Cited by 250
Abizaid, A. S., Clark, C. E., Mintz, G. S., Dosa, S., Popma, J. J., Pichard, A. D., Satler, L. F., Harvey, M., Kent, K. M., & Leon, M. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00833-9 · Cited by 224
Szczech, L. A., Best, P. J., Crowley, E., Brooks, M. M., Berger, P. B., Bittner, V., Gersh, B. J., Jones, R., Califf, R. M., Ting, H. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016051.33225.33 · Cited by 220
Rubenstein, M. H., Harrell, L. C., Sheynberg, B. V., Schunkert, H., Bazari, H., & Palacios, I. F. (2000) · Circulation · doi:10.1161/01.cir.102.24.2966 · Cited by 213
Renal Replacement Therapy for Acute Renal Failure
Murray, P. T., & Hall, J. W. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.ncc400 · Cited by 77
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Bellomo, R., Kellum, J. A., & Ronco, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61454-2 · Cited by 2,598
Metadata
- Authors
- Marenzi, G., Marana, I., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Trabattoni, D., Fabbiocchi, F., Montorsi, P., & Bartorelli, A. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-02
- Volume
- 349
- Issue
- 14
- Pages
- 1333-1340
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1971468596
- Cited by
- 504
- References
- 23
- FWCI
- 28.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.